1. Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association;Roger;Circulation,2012
2. Determination that Bretylium Tosylate Injection, 50 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register / Vol. 76, No. 243 / Monday, December 19, 2011 / Notices. 78699-78670. https://www.federalregister.gov/documents/2011/12/19/2011-32367/determination-that-bretylium-tosylate-injection-50-milligramsmilliliter-was-not-withdrawn-from-sale.
3. Part 6: advanced cardiovascular life support section 1: introduction to ACLS 2000: overview of recommended changes in ACLS from the guidelines 2000 conference originally published 22 Mar 2018;Circulation,2000
4. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias;Heissenbuttel;Ann Intern Med,1979
5. Vaughan Williams EM Classification of antiarrhythmic drugs. E Sandoe, E Flensted-Jensen, K Olesen, eds. Symposium Cardiac Arrhythmias. Stockholm, Sweden Astra1970;449-472.